Regency Centers Corporation : The downward trend is still in force
| Entry price | Target | Stop-loss | Potential |
|---|
|
US$45.45 |
US$40.1 |
US$51 |
+11.77% |
|---|
The underlying trend currently is to the downside for stocks in Regency Centers Corporation. The trend should continue over the coming trading sessions and thereby open the door for lower price targets.
Summary● The company has poor fundamentals for a short-term investment strategy.
● The group's activity appears highly profitable thanks to its outperforming net margins.
● This company will be of major interest to investors in search of a high dividend stock.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● One of the major weak points of the company is its financial situation.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 57.43 times its estimated earnings per share for the ongoing year.
● Analysts covering the stock have recently lowered their earnings forecast.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
REGENCY CENTERS CORPORATION 
